           In the United States Court of Federal Claims
                                  OFFICE OF SPECIAL MASTERS
                                           No. 15-0433V
                                       Filed: June 11, 2015
                                           Unpublished

****************************
CHRIS JUDAY,               *
                           *
              Petitioner,  *                                Dismissal; Zostavax; Shingles Vaccine;
                           *                                Vaccine Not Covered by Program;
v.                         *                                Insufficient Proof; Failure to Prosecute;
                           *                                Failure to Follow Court Orders; Special
                           *                                Processing Unit (“SPU”)
SECRETARY OF HEALTH        *
AND HUMAN SERVICES,        *
                           *
              Respondent.  *
****************************

Samuel R. Robinson, Church, Church, Hittle & Antrim, Noblesville, IN, for petitioner.
Sarah C. Duncan, U.S. Department of Justice, Washington, DC, for respondent.

                                                DECISION 1

Vowell, Chief Special Master:

       On April 29, 2015, petitioner filed a petition for compensation under the National
Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. 2 [the “Vaccine
Act” or “Program”]. The petition alleges that petitioner sustained various injuries as a
result of his receipt of the Zostavax vaccine on March 2, 2014.

        On May 7, 2015, I issued an Order to Show Cause informing petitioner that the
Zostavax (shingles) vaccine is not covered under the Program. The order afforded
petitioner 30 days, until June 8, 2015, to amend the petition or otherwise show cause
why the petition should not be dismissed. It also provided petitioner with information on
how to voluntarily exit the Vaccine Program, if he desired. The order concluded by
1
  Because this unpublished decision contains a reasoned explanation for the action in this case, it will be
posted on the United States Court of Federal Claims' website, in accordance with the E-Government Act
of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501
note (2006)). In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2
 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2006).
informing petitioner that non-compliance would be interpreted as either a failure to
prosecute the claim or as an inability to provide necessary support for the claim. The
petition would be dismissed in either event.

        On May 11, 2015, petitioner filed evidence supporting his Zostavax claim, to
include a copy of his birth certificate, proof of Zostavax vaccination, various medical
records, and an affidavit. Petitioner, however, did not thereafter file an amended
petition showing receipt of a Program-covered vaccine or any other statement,
argument, or evidence showing why his initial petition should not be dismissed.

       To be entitled to compensation under the Vaccine Act, a petitioner must
demonstrate that he or she received a vaccine set forth in the Vaccine Injury Table [the
“Table”]. See §11(c)(1)(A). Compensation is awarded only to individuals “who have
been injured by vaccines routinely administered to children.” H.R. Rep. 99-908, 1986
U.S.C.C.A.N. 6344 at 3. Such vaccines are designated in the Table. See 42 C.F.R.
§100.3 (2011). Zostavax does not appear in the Table and is therefore not covered by
the Program. Unlike the varicella vaccine routinely administered to children, Zostavax is
for immunization against varicella zoster (shingles) and is only administered to adults. 3

       Previous petitions seeking compensation for injury resulting from the shingles
vaccine have been dismissed. See, e.g., Scanlon v. Sec’y of HHS, No. 13-219V, 2013
WL 5755061 (Fed. Cl. Spec. Mstr. Sept. 27, 2013), aff’d, 114 Fed. Cl. 135 (2013);
Nilsen v. Sec’y of HHS, No. 10-110V, 2010 WL 1753471 (Fed. Cl. Spec. Mstr. Apr. 6,
2010); Doe/44 v. Sec’y of HHS, No. [redacted]V, 2009 WL 3124758 (Fed. Cl. Spec.
Mstr. Sept. 25, 2009); Doe/47 v. Sec’y of HHS, No. [redacted]V, 2009 WL 3416368
(Fed. Cl. Spec. Mstr. Sept. 10, 2009).

        It is petitioner’s duty to prosecute his claim and comply with court orders. Failure
to execute this duty risks dismissal of the petition. Tsekouras v. Sec’y, HHS, 26 Cl. Ct.
439 (1992), aff’d per curiam, 991 F.2d 810 (Fed. Cir. 1993); Sapharas v. Sec’y, HHS, 35
Fed. Cl. 503 (1996); Vaccine Rule 21(b). The show cause order clearly informed
petitioner that dismissal would result if he did not file an amended petition alleging injury
from a Program-covered vaccine or otherwise explain why his petition should not be
dismissed. In this case, petitioner neither filed an amended petition nor explained why
his petition should not be dismissed.

      Petitioner has failed to demonstrate that he received a vaccine covered under the
Vaccine Program. This case is dismissed for insufficient proof and for failure to
prosecute. The clerk shall enter judgment accordingly.


                                       s/Denise K. Vowell
                                       Denise K. Vowell
                                       Chief Special Master



3
 See Zostavax official website at www.zostavax.com (“Zostavax is a vaccine used for adults 50 years of
age or older to prevent Shingles (also known as zoster).”).
                                                    2
